In total, 131 hospitals are acting as plaintiffs. They’re asking a court to throw out 2023 changes to the Disproportionate Share Hospital calculation that altered the way Medicare Advantage and Social Security income were factored into the risk-adjusted payments hospitals receive for caring for vulnerable patient populations.
The cloud infrastructure company said in a recent investor meeting that its heavy spending on AI has been complicated by the global GPU and CPU shortage. Some 10,000 workers have reportedly been laid off, but the true number is unknown.
Clinlab.AI will oversee every aspect of this new-look laboratory, working to integrate it with the practice's workflows in a way that boosts patient care and speeds up treatment decisions.
The healthcare sector has seen an influx of funding from private equity groups over the last several years, aiding in the contraction of the industry. But has the influence of cash been beneficial for healthcare?
After seeing telehealth visits skyrocket 3,700% in April over March—most of them COVID-related—UPMC is touting its use of AI to help patients retain and apply doctors’ guidance offered during virtual visits.
CMS has finalized a rule to implement a series of proposals issued earlier this year impacting Medicare Advantage plans and Medicare Part D plan sponsors. The rules were rushed into effect to get them out before the contract year 2021 bid deadline in June.
While emerging conventional wisdom may state biopharmaceutical companies could see a boon as a result of the COVID-19 pandemic thanks to new treatment and vaccine opportunities, the sector may not come out on top.
Biopharmaceutical company AstraZeneca has received more than $1 billion in funding from BARDA for the development, production and delivery of Oxford University's vaccine for COVID-19.
